Alcohol Exposure Altered Cannabinoid Control of Monoamine Synthesis in Rat Brain

Alcohol treatment changed how a cannabinoid agonist regulated monoamine synthesis in rat brain. The changes depended on the brain region, transmitter system and exposure stage, making the finding more specific than a general claim of alcohol–cannabis cross-tolerance.

The cannabinoid challenge was WIN 55,212-2

Researchers administered the synthetic cannabinoid agonist WIN 55,212-2 and measured synthesis-related responses involving dopamine, noradrenaline and serotonin pathways. Comparisons included control rats, alcohol-treated rats and rats in withdrawal. These were brain biochemical measurements, not tests of driving or subjective intoxication.

Responses differed across regions

In controls, WIN increased noradrenaline-related synthesis in the locus ceruleus region and hippocampus while reducing dopamine-related synthesis in the striatum. It also reduced serotonin-related synthesis in the regions examined. Alcohol exposure blunted or abolished several of these responses, but the pattern varied between acute treatment, chronic treatment and withdrawal. The hippocampal noradrenaline-related response, for example, was reduced only in the chronic-withdrawal group described in the abstract.

Functional desensitization is outcome-specific

The authors interpreted the results as functional desensitization of CB1 receptors controlling monoamine synthesis. That conclusion is tied to those signaling functions. It does not mean every cannabinoid response was diminished, or that a person with alcohol tolerance will experience less cannabis impairment.

This study helps explain why exposure history can modify a later drug response without making two drugs interchangeable. Translating it requires preserving the actual compound, species, brain region and biochemical endpoint rather than substituting a broad statement about human tolerance.

Related: interpreting cannabis tolerance claims.

Research cited

Moranta D; Esteban S; García-Sevilla JA. Ethanol desensitizes cannabinoid CB1 receptors modulating monoamine synthesis in the rat brain in vivo. Neuroscience letters (2006). doi:10.1016/j.neulet.2005.08.061. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

A laboratory can identify a drug while relying on outside information to classify its prescription status. A national urine-testing study combined analytical results with medication information supplied by the ordering clinician. Two information streams McClure and colleagues analyzed 231,228 test-result sets from 144,535 patients tested for both opioids and benzodiazepines….

Spread the love

Read Article: How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

How Did a Stress-Management Trial Protocol Handle Medication Changes?

When a study evaluates psychological treatment, medication changes can complicate attribution of improvement. The 2017 Seren@ctif protocol described how investigators planned to address this issue in a trial of adjustment disorder with anxiety. The planned comparison Servant and colleagues proposed three randomized groups receiving computer-based stress management, an equivalent face-to-face…

Spread the love

Read Article: How Did a Stress-Management Trial Protocol Handle Medication Changes?

What Evidence Supports Extending Lipid Rescue to a Different Poison?

A treatment that appears useful for one toxicant raises a separate scientific question when proposed for another. Eisenkraft and Falk’s 2016 review of lipid emulsion and chemical-agent poisoning provides an example of that evidence gap. Several evidence types The authors discussed proposed lipid-scavenging, metabolic, and cardiovascular mechanisms. They reviewed laboratory…

Spread the love

Read Article: What Evidence Supports Extending Lipid Rescue to a Different Poison?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us